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Speciﬁcation
DifferentiationEnteroendocrine cells of the gastrointestinal (GI) tract play a central role in metabolism, digestion, satiety and
lipid absorption, yet their development remains poorly understood. Here we show that Arx, a homeodomain-
containing transcription factor, is required for the normal development of mouse and human enteroendocrine
cells. Arx expression is detected in a subset of Neurogenin3 (Ngn3)-positive endocrine progenitors and is also
found in a subset of hormone-producing cells. In mice, removal of Arx from the developing endoderm results
in a decrease of enteroendocrine cell types including gastrin-, glucagon/GLP-1-, CCK-, secretin-producing cell
populations and an increase of somatostatin-expressing cells. This phenotype is also observed in mice with
endocrine-progenitor-speciﬁc Arx ablation suggesting that Arx is required in the progenitor for enteroendo-
crine cell development. In addition, depletion of human ARX in developing human intestinal tissue results in
a profound deﬁcit in expression of the enteroendocrine cell markers CCK, secretin and glucagon while expres-
sion of a pan-intestinal epithelial marker, CDX2, and other non-endocrine markers remained unchanged.
Taken together, our ﬁndings uncover a novel and conserved role of Arx in mammalian endocrine cell develop-
ment and provide a potential cause for the chronic diarrhea seen in both humans and mice carrying Arx
mutations.
© 2012 Elsevier Inc. All rights reserved.Introduction
The mammalian gastrointestinal (GI) tract is lined with a single
layer of epithelial cells that undergo continuous renewal throughout
life. In the stomach and intestine, the self-renewing stem cells are
the source of all epithelial cell types and are located in the neck of
the gastric glands and in the crypts of intestine (Mills and
Shivdasani, 2011; Simons and Clevers, 2011). Epithelial cell types in
the stomach include mucin-secreting cells, pepsinogen-producing
chief cells and acid-secreting parietal cells, whereas the intestine
has absorptive enterocytes, mucus-secreting goblet cells, lysozyme-
producing Paneth cells and secretory tuft cells (Gerbe et al., 2009,
2011; May and Kaestner, 2010). In addition, enteroendocrine cells se-
creting at least 15 different hormones are found interspersed along
the epithelium of the digestive tract (May and Kaestner, 2010; Rindi
et al., 2004).Room 516E, Philadelphia, PA
ay).
rights reserved.Representing one of the complex endocrine systems in the body, the
enteroendocrine system plays a central role in metabolism, digestion,
satiety and lipid absorption (Beglinger and Degen, 2004; Drucker,
2007a,2007b; Gershon, 1968; Mellitzer and Gradwohl, 2011; Murphy
and Bloom, 2006; Murphy et al., 2006; Rehfeld, 2004a,2004b). The
importance of these cells is demonstrated by studies in which patients
with malabsorptive diarrhea were found to have mutations in the
NEUROGENIN3 gene, which resulted in undetectable enteroendocrine
cells (Rubio-Cabezas et al., 2011; Wang et al., 2006). Despite the un-
equivocal importance of enteroendocrine cells in the regulation of
diverse biological processes, there is a deﬁciency in our understanding
of how the speciﬁc enteroendocrine subtypes are generated during GI
development in mice and humans.
The mechanism by which enteroendocrine cells regulate the
above biological processes is via an array of secreted hormones. In
the intestine, cholecystokinin (CCK) is known to promote digestive
enzyme release and gallbladder contraction, secretin is important to
stimulate pancreatic enzyme release and biliary bicarbonate produc-
tion, and glucagon-like peptide-1 (GLP-1) is involved in potentiating
glucose-dependent insulin secretion and inhibits gastric emptying
(Baggio and Drucker, 2007; Lloyd, 1994; Murphy and Bloom, 2006;
Rehfeld, 2004b; Wren, 2008). In the stomach, hormones such as
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gastric acid release, respectively, while ghrelin is critical to control
appetite (Schubert, 2010; Wren and Bloom, 2007; Wren et al., 2001).
Several transcriptional regulators have been shown in mice to reg-
ulate development of the enteroendocrine cells (May and Kaestner,
2010). While some factors are required for general endocrine cell
differentiation (i.e. Neurogenin3 (Ngn3), Math1), others are only nec-
essary to specify enteroendocrine subtypes. Ngn3, a proendocrine
transcription factor, is necessary for the formation of enteroendocrine
progenitors in the GI tract, as Ngn3-deﬁcient mice display a complete
and a partial loss of enteroendocrine cells in the intestine and stom-
ach, respectively, similar to what has been reported in humans
(Jenny et al., 2002; Lee et al., 2002; Mellitzer et al., 2010; Wang
et al., 2006). In addition,Math1 null mice show a complete deﬁciency
in all secretory lineages including enteroendocrine cells, Paneth cells,
and goblet cells in the intestine (Yang et al., 2001). In contrast,
homeodomain transcription factors such as Pax4, Pax6, Nkx6.1,
Nkx2.2, Nkx6.3, and Pdx1 are involved in the differentiation of spe-
ciﬁc enteroendocrine cell types (Choi et al., 2008; Guz et al., 1995;
Jonsson et al., 1994, 1995; Larsson et al., 1996, 1998; Ofﬁeld et al.,
1996). Taken together, these studies, largely in mice, demonstrate
the importance of transcriptional regulation in enteroendocrine
cell differentiation in the GI tract and provide the basic framework
for our current understanding of how these specialized cells are
formed during development. However, the mechanism of cell fate
determination of such a diverse group of hormone producing cells
from a single Ngn3+ progenitor population (Schonhoff et al., 2004)
is largely unknown.
Here, we report a previously unappreciated role for Arx, a gene
encoding a prd-homeodomain-containing transcription factor, during
enteroendocrine cell development in mice and humans. We ﬁnd that
Arx is expressed in a subset of Ngn3+-endocrine progenitors and a
subset of mature hormone producing-cells in the developing GI
tract and that Arx is required for development of enteroendocrine
population. Furthermore, the requirement of ARX was further exam-
ined in human proximal intestinal organoids generated from human
embryonic stem (hES) cells (Spence et al., 2011), where ARX knock-
down resulted in a signiﬁcant decrease in the enteroendocrine cell
markers CCK, secretin and glucagon.
Taken together, this study is the ﬁrst to establish Arx as a novel and
important factor during enteroendocrine cell differentiation in both
mouse and human. Analysis performed in mice further shows that Arx
functions in the Ngn3+ endocrine progenitors to promote gastrin, glu-
cagon/GLP-1, CCK and secretin lineages, while simultaneously repres-
sing the somatostatin cell lineage in the GI tract. Given that both
Arx-deﬁcientmice and patients with ARXmutations suffer chronic diar-
rhea (Itoh et al., 2010; Kato and Dobyns, 2005), these ﬁndings also pro-
vide strong evidence that the primary cause of diarrhea in these
patients is likely due to alterations of speciﬁc enteroendocrine cell
populations.Methods
Mice and tissue preparation
CD1 wild-type mice were used for characterizing Arx expression.
Arx is X-linked and the derivation of the ﬂoxed conditional allele
(ArxL/L), Foxa3-Cre, Ngn3-Cre and Villin-Cre mouse lines has been
reported previously (el Marjou et al., 2004; Fulp et al., 2008; Lee
et al., 2005; Schonhoff et al., 2004). These mice were maintained
on a mixed background (CD1, 129 and C57BL/6) and were cared
and handled according to the Children's Hospital of Philadelphia's
Institutional Animal Care and Use Committee approved protocol.
Timed pregnancies were determined based on the appearance of
the vaginal plugs and were considered embryonic day (E) 0.5.Primers for genotyping alleles used in this study were described pre-
viously (Fulp et al., 2008; Lee et al., 2005; Schonhoff et al., 2004).
Real-time PCR analysis
All tissue dissections were performed in cold 1X PBS, and the tail
snips were used for genotyping. Total RNA was extracted in TRIZOL
(Invitrogen) using the RNA Easy kit (Qiagen). Oligo-dT, superscript
plus other required reagents were used to synthesize cDNA. PCR reac-
tions were set up using the Brilliant SYBR Green PCR Master Mix in
the Stratagene Mx3005P Real-time PCR machine. All reactions were
performed in triplicate with reference dye normalization. Primer se-
quences are available upon request.
Immunohistochemistry and histology
Tissues were ﬁxed in 4% paraformaldehyde overnight at 4 °C and
embedded in parafﬁn or optimal cutting temperature (OCT) freezing
medium, and 8 μm sections collected. Slides were subjected to micro-
wave antigen retrieval in 10 mmol/L sodium citrate buffer (pH 6.0).
Endogenous peroxidase activity was blocked with 3% H2O2 in PBS for
15 min, and sections blocked with CAS-Block reagent (Invitrogen).
The sections were incubated with primary antibodies overnight at
4 °C and appropriate secondary antibodies for 2 h at room temperature.
Immunohistochemical detection was performed with the VECTASTAIN
ABCkit (Vector Laboratories) and diaminobenzidine tetrahydrochloride
(DAB) as the substrate. The primary antibodies used were: Glucagon
(1:3000; Millipore), Somatostatin (1:3000; Santa Cruz), Arx (1:500;
gift from Dr. Kanako Miyabayashi at Kyushu University), Pdx1 (1:200;
Santa Cruz), Ghrelin (1:200; Santa Cruz), Isl-1 (1:50; Developmental
Studies Hybridoma Bank 39. 4D5 and 40.2D6), Gastrin (1:200; Santa
Cruz), 5-hydroxytryptamine: 5-HT (Serotonin) (1:50,000; ImmunoStar),
Chromogranin A (1:3000; DiaSorin), Neurogenin 3 (1:500; Develop-
mental Studies Hybridoma Bank), GLP-1(1:500; Abcam), CCK (1:100;
Santa Cruz), DCAMKL1 (1:100; Abcam), Muc2 (1:750; Santa Cruz),
Lysozyme (1:3000; Dako), Cdx2 (1:500; Biogenex). Sections were
stained with Hematoxylin and eosin (H&E), Alcian blue, and Oil-Red-
O according to the standard protocols. Oil-Red-O staining was per-
formed using frozen sections.
Hormone cell quantiﬁcation
The hormone-positive cells from antrum and corpus of the stom-
ach were counted, combined and normalized to the total epithelial
area of the same or adjacent section for the analyses in ArxEndoderm
and control mice. Separate regions (antrum and corpus) of the stom-
ach were counted and normalized to the respective epithelial areas
of the same or adjacent section for the analyses in ArxEndocrine and
control mice. Hormone-positive cells from different regions of the
intestine were counted and normalized to the respective epithelial
area of the same or adjacent section. Epithelial area was measured
with Aperio Image Analysis System.
Blood glucose measurement
Blood glucose was measured using an automatic glucometer (One
Touch Ultra; LifeScan, Milpitas, CA).
hES-derived intestinal organoid culture
The human ES cell line WA09 was obtained from WiCell and
maintained in feeder-free conditions on Matrigel (BD Biosciences)
in mTesR1 medium (Stem Cell Technologies). Stable shRNA knock-
down lines were generated by lentiviral-mediated transduction of
single-cell suspensions with MISSION shRNA clones from Sigma-
Aldrich (ARX shRNA: TRCN0000016333; non-targeting control
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puromycin and maintained under selection throughout differentia-
tion protocols. Human intestinal organoids were generated as previ-
ously described (Spence et al., 2011). Brieﬂy, ES cells were plated in a
24-well plate and grown to near-conﬂuency. To generate deﬁnitive
endoderm, cells were treated with Activin A (100 ng/ml; R&D Sys-
tems) for 3 days in RPMI 1640 medium (Invitrogen) in the presence
of 0%, 0.2%, and 2% dFBS (Thermo Scientiﬁc) on days 1, 2, and 3, respec-
tively. Endoderm cells were then cultured in DMEM/F12medium (Invi-
trogen) in the presence of 2% dFBS, Wnt3a (500 ng/ml; R&D Systems),
and FGF4 (500 ng/ml; R&D Systems) for 3–4 days. Floating spheroids
generated from the hindgut cultures were embedded in Matrigel
(BD Biosciences) and cultured in DMEM/F12 medium supplemented
with 10 μMHEPES, N2 Supplement (R&D Systems), B27 Supplement
(Invitrogen), R-Spondin (500 ng/ml; R&D systems), Noggin
(100 ng/ml; R&D Systems), and EGF (50 ng/ml; R&D Systems).
Human intestinal organoids were passaged into fresh Matrigel every
14 days.
Results
Arx is expressed in a subset of enteroendocrine cells in the GI epithelium
Immunostaining analysis was performed to characterize the tem-
poral and spatial expression domains of Arx in the developing stom-
ach and intestine of mice. While Arx expression was strong in the
pancreas at embryonic day (E)13.5, its expression was not detectable
in the stomach and intestine at this stage (data not shown). A day
later, Arx expression was detected at a low frequency in the duode-
num, but not in the stomach (Fig. 1a and data not shown). At E15.5,
the GI epithelium begins to differentiate and form gastric units and
nascent villi and shortly after this (~E17.5), Arx-expressing cells can
be found along the crypt-villus axis in the entire developing digestive
tract (Fig. 1b–f). We assessed whether Arx expression was restricted
to enteroendocrine cells using chromogranin A (ChrA), an pan-
endocrine cell marker, in postnatal day (P)3 stomach and duode-
num, and found that Arx expression was restricted to a subset of
the ChrA-positive cells (Fig. 1g and h). To evaluate which enteroen-
docrine subtypes express Arx, we analyzed Arx expression in speciﬁc
gastrointestinal hormone-expressing cells. In the P3 stomach, Arx ex-
pression was localized to gastrin-, glucagon-, serotonin-, somatostatin-,
and ghrelin-expressing cells (Fig. 1i–m). In the duodenum, Arx ex-
pression was found in enteroendocrine subpopulations including
cholecystokinin- (CCK), ghrelin-, glucagon-, GLP-1-, and serotonin-
positive cells (Fig. 1n–r). Interestingly, we did not detect co-
localization of Arx with somatostatin in the duodenum (Fig. 1s).
Lastly, Arx expression was not detected in the intestinal Paneth,
tuft or goblet cells at all ages examined (Fig. 1t–w and data not
shown). Taken together, these results indicate that Arx is restricted
to a speciﬁc subset of enteroendocrine cells.
Arx expression is found in subsets of Pdx1+, Ngn3+ and isl-1+ cells
To investigate when Arx might function during enteroendocrine
development, we compared Arx expression with key transcriptional
regulators (Pdx1, Ngn3, or Isl-1) that have been associated with
speciﬁc developmental stages of enteroendocrine cell differentiation
(Das and May, 2011; Guz et al., 1995; Jenny et al., 2002; Jonsson
et al., 1994, 1995; Larsson et al., 1995; Lee et al., 2002; Mellitzer
et al., 2010; Ofﬁeld et al., 1996). At E17.5, very few Arx-positive
cells co-expressing Pdx1 or Ngn3 were found in the stomach and
duodenum (Supple. Fig. 1a–i and data not shown). In addition, a
few cells co-expressing Arx and Isl-1 were detected in the duodenum
(Supple. Fig. 1j–l). As Ngn3 marks endocrine progenitors and Isl-1
labels differentiated endocrine cells (Das and May, 2011; Jenny
et al., 2002; Lee et al., 2002; Schonhoff et al., 2004), these ﬁndingssuggest that Arx functions downstream of Ngn3 in the subset of undif-
ferentiated endocrine progenitors and/or in the differentiated endo-
crine cells of the GI epithelium.
Endoderm-speciﬁc Arx-deﬁcient mice exhibit growth retardation and
chronic diarrhea
To examine the functional consequences of Arx deﬁciency in the
epithelium of the GI tract, including stomach and intestine, we gen-
erated mice with Arx deletion in the developing endoderm (Foxa3-
Cre; ArxL/L or Foxa3-Cre; ArxL/Y; referred to as ArxEndoderm mutant
hereafter) by intercrossing Foxa3-Cre mice to Arx-ﬂoxed mice (Fulp
et al., 2008; Lee et al., 2005). We assessed the efﬁciency of Arx re-
moval in the developing stomach and intestine at the onset of enter-
oendocrine cell differentiation at E17.5. Compared to the control
mice, ArxEndoderm mutants lacked all Arx-expressing cells at E17.5
in the stomach and duodenum (Fig. 2a–d and data not shown). Mu-
tants were born at the expectedMendelian ratio andwere outwardly
indistinguishable from their control siblings at birth. However, in the
next few days, ArxEndoderm mutants fell behind their control littermates
in growth (Fig. 2e–f). By the end of the ﬁrst week, all ArxEndoderm mu-
tant animals had severe diarrhea and half of these mice died, the
other half of the mutants survived past weaning and appeared gross-
ly normal albeit reduced in size, and continued to have diarrhea
(Fig. 2g). Early lethality was not due to lack of feeding as all mutant
mice had milk in their stomach (Fig. 2h). Although the digestive
tract was smaller and shorter in the ArxEndoderm mutants compared
to the control littermates, these reductions were proportional to
the length and body weight of the ArxEndoderm mutant mice (Fig. 2h
and data not shown). In our macroscopic analyses of the ArxEndoderm
mutants, we observed dilation in the ileum (arrows; Fig. 2h). Lastly,
P3 ArxEndoderm mutant mice also displayed relative hypoglycemia
(Fig. 2i), which can result from malnourishment due to chronic diar-
rhea (as discussed below) and/or due to islet glucagon cell deﬁciency
in the pancreas (Collombat et al., 2003).
Abnormal architecture observed in the ileal epithelium of ArxEndoderm
mutant mice
The impact of Arx removal on the overall histology of the GI epi-
thelium was next assessed. Hematoxylin and eosin stained tissue sec-
tions from the control and ArxEndoderm mutant mice revealed normal
architecture of the stomach, duodenum and colon; however, in the
ileumwe observed abnormal vacuoles in the enterocytes of ArxEndoderm
mutant mice (Fig. 2j–q). Since Arx expression is not restricted to the
ileum or found in enterocytes (data not shown), the histological
changes seen in the ileum are likely secondary to the loss of Arx in
enteroendocrine cell populations (see below for further discussion).
Gut hormones critical for digestion and motility are affected in ArxEndoderm
mutant mice
As Arx is expressed in developing and postnatal enteroendocrine
cells (Fig. 1 and Supple. Fig. 1), we investigated the impact of Arx
deletion on formation of enteroendocrine cells using the pan-
endocrine marker ChrA. While the total number of ChrA-positive
enteroendocrine cells remained unchanged, the proportion of
serotonin- and somatostatin-expressing cells was increased, and
the frequency of gastrin- and glucagon-expressing cells was reduced
in the P3 ArxEndoderm mutant stomach (Fig. 3a–j). Although Arx expres-
sion was detected in a subset of ghrelin-expressing cells (Fig. 1m), we
did not detect a difference in the number of this cell type (Fig. 3k–l).
Similar analyses were conducted in the P3 duodenum where we
found a signiﬁcant increase in the number of somatostatin-expressing
cells (Fig. 3o–p) and a dramatic reduction in the number of CCK-,
glucagon-, and GLP-1-expressing cells (Fig. 3q–v). The number of
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number of ChrA-positive enteroendocrine cells (Fig. 3m–n and w–z). In
addition, similar changes in the enteroendocrine cell types were ob-
served in the P3 jejunum and ileum of ArxEndoderm mutant mice
(Supple. Fig. 2 and data not shown). Real-time PCR analysis conﬁrmed
changes in expression levels of these hormone genes andadditionally observed a decrease in TPH-1 and secretin mRNA levels
in the P3 ArxEndoderm stomach and duodenum (Supple. Fig. 3a–b).
While deﬁciency of several gastrointestinal transcriptional regula-
tors including Pax4, Pax6, Nkx6.1, Nkx2.2, Nkx6.3, and Pdx1 has
been shown to play a role in the development of enteroendocrine
populations that were affected in the ArxEndoderm mice, we did not
181A. Du et al. / Developmental Biology 365 (2012) 175–188detect any changes in the expression levels of any of these genes in
the P3 ArxEndoderm stomach and duodenum (Supple. Fig. 3c-d).
Arx is required in endocrine progenitors to specify cell fate choices
Arx is localized to a very few somatostatin cells in the stomach and
is completely absent in these cells of the duodenum (Fig. 1l and s) and
yet there is a dramatic increase in the number of this cell type in the
ArxEndoderm mutant mice (Fig. 3e–f and o–p). There are several possi-
ble explanations for the increase of somatostatin cell population seen
in the ArxEndoderm mutant mice, however one explanation is that Arx
may play a cell fate decision role in the endocrine progenitors and
that these cells become redirected into the somatostatin lineage
when the Arx-dependent pathway is deleted. Alternatively, the in-
crease in the somatostatin cell number could be due to fate switching
from another enteroendocrine cell type upon Arx removal. To test the
former possibility, we deleted Arx speciﬁcally in the Ngn3+ endocrine
progenitors (ArxEndocrine mutant mice) by intercrossing Ngn3-Cre
mice to Arx-ﬂoxed mice (Fulp et al., 2008; Mastracci et al., 2011;
Schonhoff et al., 2004). As enteroendocrine populations are known
to show stereotypical variation across different regions of the stom-
ach, (Fig. 4u; left image; (Jensen et al., 2000; Rindi et al., 2004)), we
analyzed changes in enteroendocrine cell numbers speciﬁcally in
the gastric corpus and antrum of P5 control and ArxEndocrine mutant
mice. Similar to what we have observed in the ArxEndoderm mice, the
number of somatostatin-expressing cells increased dramatically in
the antrum, but not in the corpus (Fig. 4a–b). In contrast, glucagon-
and gastrin-expressing cells were profoundly reduced in the corpus
and antrum, respectively (Fig. 4c–f). We observed no signiﬁcant
increase in the numbers of serotonin-positive cells in the antrum or
corpus; in contrast to what we had seen in the ArxEndoderm mutant
stomach (Figs. 3c–d and 4g–h). Lastly, we did not detect changes in
the number of ChrA-expressing cells in either the antrum or corpus
of ArxEndocrine mutant mice (Fig. 4i–j). These data suggest that in
the stomach Arx is required in the Ngn3+ endocrine progenitors to
control cell fate choices for glucagon, gastrin and somatostatin, but
not serotonin lineages. Alternatively, there may be an existence of
endocrine precursor population that is positive for Arx, but devoid
of Ngn3 expression that can also give rise to serotonin lineage in
the stomach (see below for further discussion).
In the duodenum of ArxEndocrine animals, there was an increase
in the numbers of somatostatin-expressing cells and a reduced num-
ber of glucagon-, GLP-1, and CCK-expressing cells, while the number
of serotonin-expressing cells remained unchanged (Fig. 4k–t). The
striking similarities in the changes of intestinal enteroendocrine
cell populations between ArxEndoderm and ArxEndocrine mice strongly
suggest that Arx is largely acting in endocrine progenitors to control
speciﬁcation of distinct subtypes of enteroendocrine lineages
(Fig. 4u).
GI dysfunction and alterations in enteroendocrine cell populations are
observed in ArxIntestine mutant mice
Arx also plays a critical role in islet alpha cell development in the
pancreas (Collombat et al., 2003) and pancreatic dysfunction has been
postulated to contribute to the diarrhea seen in patients with ARXmu-
tations (Itoh et al., 2010). To determinewhether the ArxEndodermmutant
intestinal phenotypes are independent of the known role of Arx in
pancreas development, we generated intestine-speciﬁc Arx-deﬁcient
mice (Villin-Cre; ArxL/L or Villin-Cre; ArxL/Y; referred to as ArxIntestine mu-
tant hereafter) by intercrossing Villin-Cre transgenic mice to Arx-ﬂoxed
mice (el Marjou et al., 2004; Fulp et al., 2008). We found that al-
though ArxIntestine mutant mice have normal survival curves, they
too suffered from chronic diarrhea with mildly reduced glucose
levels compared to control mice at P3 (95±6.5 mg/dl for controls
and 58±8 mg/dl for mutants). These ﬁndings demonstrate thatintestinal Arx loss is the predominant cause for the diarrhea and
hypoglycemia in ArxEndoderm mice and that loss of Arx in the pan-
creas of these mutant mice only contributes to the hypoglycemia
phenotype.
Immunostaining of intestinal tissue from adult ArxIntestine mutant
mice was performed which showed an increase in somatostatin-
expressing cells and decreases in CCK, glucagon/GLP-1 cell popula-
tions in the duodenum (Supple. Fig. 4). Furthermore, analysis of
the ArxEndoderm mice that survived to adulthood showed that they
continued to have soft stool and exhibited similar changes in the
enteroendocrine populations in the stomach and duodenum (data
not shown). These results suggest that although older mice continue
to have chronic diarrhea likely due to enteroendocrine cell dysfunc-
tion, survival is not affected beyond early stages of their lives.
Lipid accumulation in the ileum of ArxEndoderm and ArxIntestine mutant mice
The cause of chronic diarrhea was next evaluated in Oil-red-O
stained fecal samples from P3 ArxEndoderm and ArxIntestine mutant
mice, which showed an increased in staining indicating potential de-
fects in the intestinal fat absorption (Fig. 5a–b and Supple. Fig. 5a–b).
To further investigate this defect, different regions of the intestine
were stained with Oil-red-O in which excess lipid accumulation was
evident only in the ileum of ArxEndoderm mutant mice (Fig. 5c–f and
data not shown). These ﬁndings demonstrate that the abnormal vacu-
oles seen in the ileum of ArxEndoderm were in fact lipid droplets
(Fig. 2n–o). Excess lipid accumulation was also observed in the ileum
of P3 ArxIntestine and ArxEndocrine mutants (Supple. Fig. 5c–f and data
not shown). Taken together, these ﬁndings suggest that intestinal Arx
deﬁciency impacts development of several enteorendocrine cell popu-
lations, whose functions include the regulation of lipid processing
and/or metabolism in the neonatal intestine.
Lastly, since the goblet cell number was increased in the Ngn3-null
mice at early postnatal stages and a possibility of goblet and enteroen-
docrine cells sharing part of their developmental program (Jenny
et al., 2002; Jensen et al., 2000; Poulsom et al., 1993), we examined if
there were changes in goblet cell population in our ArxEndoderm mutant
mice. Alcian blue stainings were performed and quantiﬁed in the
intestine of P3 control and ArxEndoderm mutant mice and showed no
obvious changes in the numbers of goblet cells in the duodenum
(2.25±0.16 for control and 2.39±0.32 for mutant; per villus),
ileum (4.59±0.21 for control and 4.27±0.34 for mutant; per villus)
or colon (10.22±0.37 for control and 10.54±1.2 for mutant; per
gland) (Fig. 5g–l). These observations indicate that Arx removal
and/or altered enteroendocrine cell populations in the ArxEndoderm
mutant mice have no impact on the goblet cell development.
ARX knock down in human intestinal tissue also causes
enteroendocrine cell deﬁciency
It has previously been reported that patients carrying ARX muta-
tions suffer from diarrhea (Itoh et al., 2010; Kato and Dobyns,
2005), a phenotype that is also observed in Arx-deﬁcient mice. To de-
termine if this coincides with the loss of speciﬁc enteroendocrine cells
as it does in mice, we investigated if ARX is required for normal
human enteroendocrine cell development. We performed shRNA-
mediated loss-of-function in human intestinal organoids (HIOs) de-
rived from pluripotent stem cells via directed differentiation
(Spence et al., 2011). To generate stable shRNA-ARX knockdown
lines, human ES cells were transduced with lentivirus expressing
ARX shRNA and differentiated into proximal intestinal organoids,
which had between 50 and 60% reduction in ARX mRNA levels
(Fig. 6a). HIOs were analyzed at day 68, at which time all intestinal
cell types can be observed (Spence et al., 2011). Immunostaining
analysis showed normal CDX2 expression in epithelium of the ARX
knockdown organoids as compared to control organoids, which
182 A. Du et al. / Developmental Biology 365 (2012) 175–188indicates that ARX knockdown did not inhibit the formation of a
CDX2-positive epithelium (Fig. 6b–c). Additionally, ARX knockdown
did not affect expression levels of markers for enterocytes (Lactase),P5 Stomach
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the observed regional changes of enteroendocrine populations in the stomach. Note:
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183A. Du et al. / Developmental Biology 365 (2012) 175–188CCK, Secretin, and Preproglucagon mRNA levels (Fig. 6g–l) demon-
strating that development of a subset of enteroendocrine cells is de-
pendent on the presence of ARX in humans as it is in mice.
Interestingly, Somatostatin gene expression was not increased in
ARX depleted human organoids as it was in Arx-deﬁcient mice
(Fig. 6k, Fig. 3o–p, 4k–l, Supple Figs. 3b, 4a–b). These results suggest
that human enteroendocrine cell development requires ARX and the
GI dysfunction in patients with ARX mutations may be caused by al-
tered numbers of enteroendocrine cells in the GI tract.
Discussion
The function of Arx has been identiﬁed and studied extensively in
the brain and endocrine pancreas (Collombat et al., 2003, 2005,
2007; Colombo et al., 2007; Friocourt et al., 2008; Hancock et al.,
2010; Kitamura et al., 2002; Marsh et al., 2009; Mastracci et al.,
2011), yet its role in developing GI endocrine cells has not been char-
acterized. Findings from our study not only contribute vastly to the
body of knowledge on transcriptional control of enteroendocrine
cell development in mice and humans, they also provide insights
into the pathogenesis of GI symptoms observed in patients with
ARX mutations.
Our analyses of mice deﬁcient for Arx in the developing endoderm
(ArxEndoderm) and in the intestine (ArxIntestine) show changes in thee f
i j
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colon reveals no signiﬁcant changes in the numbers of goblet cells between ArxEndoderm muenteroendocrine populations, which are likely to result in hormone
imbalance, leading to severe diarrhea. In addition, removing Arx in
Ngn3+ endocrine progenitors (ArxEndocrine) further demonstrates
that Arx is required for cell fate decisions in these cells. In fact, similar
changes in the numbers of gastric somatostatin, gastrin and glucagon
cells and intestinal somatostatin, CCK, glucagon/GLP1 cells were
observed in the ArxEndocrine and ArxEndoderm mutants. Although our
ﬁndings do not directly demonstrate that Arx is involved in favoring
certain enteroendocrine lineages at the expense of the others within
the endocrine progenitor population as demonstrated in the Arx-
deﬁcient pancreas (Collombat et al., 2003, 2005), these observations
are suggestive of such a possibility in the intestine based on the lack
of Arx expression in the somatostatin cells and a profound increase
of this cell type upon Arx removal in the endocrine progenitors.
The importance of enteroendocrine progenitors, mature enter-
oendocrine cells, and hormones secreted by these cells have been
suggested to play a critical role in maintaining overall homeostasis
of the intestinal crypt compartment (Mellitzer et al., 2010). In con-
trast to the altered cell homeostasis observed in the Ngn3-deﬁcient
adult intestine (Mellitzer et al., 2010), we did not detect any disorga-
nization in the crypts in the neonatal or adult Arx-deﬁcient mice
suggesting that the affected enteroendocrine populations in the
Arx-deﬁcient mice may not play a role in maintaining the crypt
homeostasis. Furthermore, in contrast to an increase in the gobletc d
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also did not detect changes in this cell type in the intestine of the
ArxEndoderm mice suggesting that Arx is not involved in regulating0.0
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was generated from human embryonic stem cell lines and analyzed at 68 days after
ARX mRNA (a) and a similar reduction in the proximal enteroendocrine cell markers
ocrine marker ChrA (g) or the enteroendocrine cell markers somatostatin and ghrelin
erences observed in the pan-epithelial marker CDX2 (b, c) or differentiation of enter-
d using a Student's t-test. *pb0.05. **pb0.01. Scale bars in b, c represent 200 μm.
185A. Du et al. / Developmental Biology 365 (2012) 175–188While in Arx-deﬁcient mice the gross architecture of the crypts
and villi in the gastrointestinal epithelium appears normal with pres-
ence of all intestinal cell types, an abundance of lipid-ﬁlled entero-
cytes was detected in the ileum of ArxIntestine, ArxEndoderm and
ArxEndocrine mutant mice at early postnatal stages. This phenotype is
reminiscent of the intestinal phenotype found in the Pleomorphic
adenoma gene-like 2 (PlagL2) deﬁcient pups in which lipid-ﬁlled
enterocytes were found in the jejunum (Van Dyck et al., 2007).
Since PlagL2 is expressed in the enterocytes and Arx is only found in
the enterendocrine cells, our ﬁndings suggest that enteroendocrine
subpopulations affected in the Arx-deﬁcient mice are likely hormone
cell types that are involved in regulating lipid absorption and/or
transport. Since no obvious morphological alterations or lipid-ﬁlled
enterocytes were found in the proximal intestine of the Arx-deﬁcient
mice, the lipid transport system is likely overloaded and only affect-
ed profoundly in the distal region of the intestine similar to what was
described in the distal jejunum of PlagL2 mutants at nursing ages
(Van Dyck et al., 2007). Although we cannot identify the speciﬁc hor-
mones that are responsible for regulating gut lipid metabolism, ourGall Bladder
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Interestingly, although similar hormone populations were affected
in the adult Arx-deﬁcient mice, we did not detect the presence of vac-
uoles in the ileal enterocytes in mice that were fed normal chow (data
not shown) suggesting that there is an age- and diet-speciﬁc impact
on hormone deﬁciency and lipid metabolism in the Arx mutants. As
milk contains higher fat content than the solid food that the adult
mice consume, it would be interesting to see whether placing adult
Arx-deﬁcient mice on a high fat diet would also lead to an increase
in the number of lipid-ﬁlled intestinal enterocytes similar to what
was observed in the nursing pups.
In contrast to the ArxEndoderm mutants which showed chronic diar-
rhea and reduced survival, ArxEndocrine mutant mice had a normal sur-
vival curve and did not suffer from diarrhea even though similar
hormone populations, except gastric serotonin cells, were found to
be affected profoundly in the stomach and intestine. It is important
to keep in mind that there are at least 15 enteroendocrine subtypes
present in the GI tract and Arx is selectively removed in the Ngn3+Arx Endoderm
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summary of the observed cell population changes and processes affected in ArxEndoderm
tric glucagon, somatostatin and gastrin cells. However, serotonin cells can arise fromeither
lue). All these enteroendocrine subtypes are probably derive from Ngn3+ endocrine pro-
development of somatostatin, glucagon/GLP-1, CCK and secretin cells in the intestine.
ber of gastrin-, CCK-, glucagon/GLP-1-, and secretin-expressing cells and an increase
ult in a reduction of gastric acid, pancreatic enzymes, and bile acids.
186 A. Du et al. / Developmental Biology 365 (2012) 175–188endocrine progenitors in the ArxEndocrine mutants and in all epithelial
cells in the ArxEndoderm mutants. Furthermore, it has been suggested
that gastric serotonin cell development is controlled in Ngn3-
dependent and independent fashions as this cell type is not complete-
ly missing in the stomach of Ngn3 null mice (Jenny et al., 2002; Lee
et al., 2002). Consistent with this model and if Ngn3-Cre activity in
the ArxEndocrine mutants was delayed and only present in Ngn3/Arx
endocrine progenitors of the stomach (yellow cell; Fig. 7a), then the
serotonin cell population would only be partially affected in the
ArxEndocrine mutants and more profoundly impacted in the ArxEndoderm
mutants. In fact, this is exactly what we observed in our immunos-
taining analyses for serotonin cells in the stomach of these two mu-
tants. Additionally, some unexamined enteroendocrine cells in the
stomach may also be selectively affected only in the ArxEndoderm mu-
tants. Therefore, a global gene expression analysis (e.g. RNA-seq)
will be most informative to thoroughly determine if additional genes
associated with enteroendocrine subpopulations were uniquely af-
fected in the ArxEndoderm mutants.
The chronic diarrhea seen in the ArxIntestine and ArxEndoderm mice
is also apparent in subset of patients with ARX mutations who not
only suffer from a wide variety of neurologic conditions, including
X-linked lissencephaly with abnormal genitalia (XLAG), but also
have a reduced number of pancreatic endocrine and exocrine cells
(Bienvenu et al., 2002; Gecz et al., 2006; Itoh et al., 2010; Kitamura
et al., 2002; Stromme et al., 2002a,2002b; Kato and Dobyns, 2005).
The shortened life span of these patients and mice with whole
body Arxmutations has been attributed to profound neurologic dys-
function or the complete absence of glucagon-producing alpha-cells
in the pancreas instead of endocrine cell dysfunction in the intestine
(Collombat et al., 2003; Gecz et al., 2006; Hancock et al., 2010; Marsh
et al., 2009). Our data suggest that gastrointestinal defects in pa-
tients with ARX mutations may also contribute to the overall degen-
erative condition in these patients.
It has been proposed that a deﬁciency in both pancreatic polypep-
tide and pancreatic exocrine enzymes contributes to the intractable
diarrhea in ARX patients (Itoh et al., 2010). However, we did not de-
tect a change in the number of pancreatic polypeptide-producing PP
cells nor was there a reduced amount of pancreatic amylase staining
in our ArxEndoderm mutant mice (data not shown). In addition, our
analysis of the ArxIntestine mutants, which showed similar GI dys-
function further provides evidence that the diarrhea observed in
the mice as well as the humans more likely stems from changes in
the GI hormone levels that result in loss of regulated release of di-
gestive enzymes from the exocrine pancreas.
Although animal models are ideal for identifying functions of genes
of interest, the use of hES cell-derived human intestinal tissue has
allowed us to identify both conserved and human-speciﬁc functions of
ARX during intestinal endocrine cell differentiation. For example, ARX
is required in both mice and humans for normal development of CCK,
secretin and glucagon/GLP-1-expressing cells. In contrast, ARX is
not required for development of human somatostatin-expressing
cells in the proximal intestine, similar to what has been shown in
the human pancreas (Itoh et al., 2010). These ﬁndings not only pro-
vide valuable information on basic enteroendocrine cell develop-
ment but also emphasize the importance of cell-based model systems
to study human diseases as human tissues are often difﬁcult to obtain
for such studies.
Arx is acting as a key factor in the endocrine progenitors during
enteroendocrine cell differentiation. Even though there are many
more endocrine subtypes present in the GI epithelium as compared
to the endocrine pancreas, Arx is also involved in promoting the
glucagon/GLP-1 cell populations and repressing the somatostatin
cell population in the intestine (Fig. 7b–d). Additionally Arx is also re-
quired for the development of CCK and secretin cells, two endocrine
subtypes that are unique to the intestine (Fig. 7b–d). Interestingly,
in the stomach, an increase in the somatostatin cell population wasonly detected in the antrum of ArxEndocrine mutant mice, a region
that is devoid of glucagon cells and ﬁlled with gastrin cells. The de-
crease in the gastrin cell number and the increase in the somatostatin
cell number were suggestive of a possibility that Arx might be in-
volved in promoting gastrin and repressing somatostatin cell differ-
entiation simultaneously in the antral stomach. The potential of
these two enteroendocrine populations sharing a common precursor
in the stomach is further supported by the presence of gastrin and
somatostatin co-expressing cells in addition to the cells expressing
either gastrin or somatostatin alone (Larsson et al., 1995). The devel-
opment of the gastrin and somatostatin cells has also been suggested
to be regulated by Islet-1 (Isl-1), a LIM-homeodomain transcription
factor (Larsson et al., 1995). In addition, Isl-1 plays a key role in reg-
ulating Arx expression in the islet alpha cells as Isl-1 removal in the
embryonic pancreas results in a decrease of Arx expression (Du et al.,
2009; Liu et al., 2011). Based on these observations, we hypothesize
that differentiation of gastrin and somatostatin cells is likely controlled
by a combinatorial role of Isl-1 and Arx as expression of these two
transcription factors overlaps in the stomach (unpublished data).
Lastly, lineage tracing studies will be required in the future to deter-
mine the relationship between all the hormone populations that
were affected in the Arx-deﬁcient mice and if Arx promotes one
enteroendocrine population at the expense of the other.
It has been shown that not all cells express equal levels of tran-
scription factor as demonstrated in the pancreas for Pdx1 and Ngn3
(Fujitani et al., 2006; Nishimura et al., 2006; Villasenor et al., 2008;
Wang et al., 2009). Our expression analyses show that Arx is only
found in subsets of Ngn3+ endocrine progenitors and hormone-
producing cells. One possible explanation is the potential presence
of ArxHI and ArxLO cells that are at different stages or ages within
the enteroendocrine population. In order to determine whether
ArxHI and ArxLO cells truly exist in the GI epithelium, additional Arx
antibodies with higher sensitivities or assessment of Arx expression
via LacZ staining in the Arx+/LacZ mice (Collombat et al., 2003) will
be required. Overall, our ﬁndings reveal a novel role for Arx in the
endocrine progenitor during enteroendocrine development. Future
studies on Arx in the GI tract will help determine whether Arx is
also required at later stages to maintain the mature phenotypes of
this population and to determine the molecular mechanisms by
which Arx is involved in regulating this process including regulation
of hormone gene expression.
Conclusion
Here we demonstrate that Arx is required in the endocrine pro-
genitors to specify particular enteroendocrine cell fates. The enter-
oendocrine populations affected in the absence of Arx are critical in
regulating digestion (gastrin, somatostatin, CCK and secretin) and
gut motility (serotonin and GLP-1). Therefore, changes in the number
of these cell types may affect overall physiology, including release of
gastric acid, bile, and digestive enzymes, and rate of chyme transit
in these mice (Fig. 7c–d) (Baggio and Drucker, 2007; Beglinger and
Degen, 2004; Drucker, 2007a; 2007b; Gershon, 1968; Lloyd, 1994;
Mellitzer and Gradwohl, 2011; Murphy and Bloom, 2006; Murphy
et al., 2006; Rehfeld, 2004a; 2004b; Schubert, 2010; Wren, 2008;
Wren and Bloom, 2007; Wren et al., 2001).
Our study also provides evidence that the lack of speciﬁc enteroendo-
crine cell types in the GI tract is likely the primary cause of GI dysfunction
seen in patients with ARX mutations. These ﬁndings will provide a thor-
ough understanding for designing more efﬁcient differentiation protocols
toward generation of speciﬁc enteroendocrine types in vitro and generat-
ing effective treatments for patients with ARXmutations.
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